academic article

• 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study..  Lancet neurology.  8:889-897. 2009
• Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial..  Lancet.  374:1503-1511. 2009
• Glatiramer acetate therapy for multiple sclerosis: a review..  Expert opinion on drug metabolism & toxicology.  2:1019-1029. 2006